Trial intelligence / Profile preview

Cannabidiol transdermal gel for painful muscular temporomandibular disorder

RBR-6xfb4xsRecruiting

Sponsor
Faculdade de Odontologia de Ribeirão Preto
Start
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, triple-blind trial of cannabidiol in temporomandibular disorder (TMD) (2 arms), sponsored by Faculdade de Odontologia de Ribeirão Preto. Started Mar 2024; status: recruiting.

02

Drugs

cannabidiol
03

Conditions

temporomandibular disorder (TMD)

Beyond the preview

Go deeper on RBR-6xfb4xs.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6xfb4xs.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call